NCT04671953View on ClinicalTrials.gov

Effect of BMS-986165 on the Blood Levels of Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

March 3, 2021

Study Completion Date

March 30, 2021

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Specified dose on specified days

DRUG

Metformin

Specified dose on specified days

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04671953 - Effect of BMS-986165 on the Blood Levels of Metformin | Biotech Hunter | Biotech Hunter